How a specific genetic variation affects blood vessel function in pulmonary arterial hypertension.
Official title: ACTN4 Binding to Functional SNP rs9277336 Controls the Genome Architecture and Endothelial Pathophenotypes in Pulmonary Arterial
Funded at University of Pittsburgh at Pittsburgh · NIH-10938016 · Data updated 2026-11-12
This study is looking at how a specific gene variation might affect a protein that helps control blood vessel function in people with pulmonary arterial hypertension (PAH), with the hope that understanding this could lead to better treatments tailored to individual patients.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | September 26, 2023 |
| Project end | March 25, 2027 |
| Funding year | 2024 |
| Award (this year) | $53,974 |
| NIH project number | 5F30HL170649-02 |
| Project ID | NIH-10938016 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with pulmonary arterial hypertension, particularly those with specific genetic variations related to the ACTN4 protein.
✕Less likely to help
Patients without pulmonary arterial hypertension or those whose condition is unrelated to the genetic factors being studied may not benefit from this research.
What this research studies
This research investigates the role of a specific genetic variation (SNP rs9277336) in pulmonary arterial hypertension (PAH), a condition that causes high blood pressure in the lungs. The study aims to understand how this genetic variation influences the binding of a protein called ACTN4, which is crucial for regulating genes involved in blood vessel function. By examining how this genetic factor affects endothelial cells, the research seeks to uncover mechanisms that contribute to the severity of PAH. Patients may benefit from insights that could lead to targeted therapies based on their genetic profiles.
Why it matters
Potential benefit: If successful, this research could lead to personalized treatment strategies for patients with pulmonary arterial hypertension based on their genetic makeup.
How similar studies have gone: Previous research has shown promising results in understanding genetic factors in pulmonary arterial hypertension, indicating that this approach could yield valuable insights.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Kirillova, Anna — University of Pittsburgh at Pittsburgh
- Study coordinator: Kirillova, Anna
Related research
Other NIH-funded projects on the same topics.
-
Elastomeric membranes for safer pelvic organ prolapse repair
A new 3D-printed elastomeric membrane made from polycarbonate urethane is being tested to replace stiff polypropylene meshes for pelvic organ prolapse in women, aiming to reduce complications.
-
Role of hyaluronan in egg development and ovarian reserve
This grant studies how the hyaluronan matrix in the ovary affects the aging of the female reproductive system and the pool of eggs available.
-
Regulatory switches that control imprinting in early human development
This grant studies how certain genes stay “one-copy” active in early development and what goes wrong in assisted reproduction, with a focus on imprinting disorders.
-
Identifying molecular signs of imprinting errors linked to fertility treatments
This grant studies how assisted reproductive technologies may cause imprinting errors in embryos and how these errors relate to certain birth conditions, with implications for families using infertility treatments.
-
Bioadhesive vaginal film for 7-day protection against HIV, HSV, and pregnancy
A vaginal film that slowly releases antibodies to prevent HIV, HSV, and unintended pregnancy for about a week from a single use.
-
Spermatogonial stem cell transplantation and culture in patients
Researchers are testing a way to transplant or grow sperm-producing cells back in boys and men who stored tissue before cancer treatment, to help them have biological children in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.